Avantor Earnings Preview: Dip Expected | Business and Finance News

Avantor’s Q2 earnings drop looms as market braces for a 4.2% revenue decline—down from last year’s 1.1% dip—despite beating estimates last quarter with $1.58B in revenue. While analysts expect steady, unexciting results, rivals like Thermo Fisher and Medpace surged with strong growth, sending their stocks soaring. Meanwhile, Avantor’s shares have climbed 16% in the past month, trading above the $10.44 average analyst target. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/aa519a24275f4a1d